Post by Cardior Pharmaceuticals

Join our Managing Director, Prof. Thomas Thum, MD, PhD, for the 2026 TFmed Therapeutics Frontiers in Medicine Conference, held next week from April 13 - 16, in Frankfurt am Main. This transdisciplinary conference will feature therapeutic approaches across cardiology, diabetes, ageing, inflammation, infection, cancer and neurodegeneration. On April 15th in the session “Cardiovascular therapeutics”, Thomas will engage in a discussion with Rui Benedito from Max Planck Institute for Molecular Biomedicine, Kristy Red-Horse from Stanford University, and Carlos Fernandez from Yale School of Medicine, on how novel therapeutic approaches could change the treatment landscape for cardiovascular indications. Thomas is looking forward to highlighting the potential of RNA-based medicines and exploring the latest developments in cardiovascular disease.